Dexrazoxane Intravenous and Pneumococcal 13-valent conjugate vaccine
Determining the interaction of Dexrazoxane Intravenous and Pneumococcal 13-valent conjugate vaccine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal Conjugate Vaccine (13-Valent)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Dexrazoxane Intravenous-Pneumococcal Conjugate Vaccine (13-Valent)
- Dexrazoxane Intravenous-Pneumococcal Conjugate Vaccine (7-Valent)
- Dexrazoxane Intravenous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Dexrazoxane Intravenous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Dexrazoxane Intravenous-Pneumovax 23
- Pneumococcal 13-valent conjugate vaccine-Dextenza Insert
- Pneumococcal 13-valent conjugate vaccine-Dextenza intraocular
- Pneumococcal 13-valent conjugate vaccine-Dextran 40
- Pneumococcal 13-valent conjugate vaccine-Dextran 70 6% in 5% Dextrose high molecular weight
- Pneumococcal 13-valent conjugate vaccine-Dextran 75
- Pneumococcal 13-valent conjugate vaccine-Dextran high molecular weight